Scholar Rock Holding Corporation logo

Scholar Rock Holding Corporation

NASDAQ:SRRK

Overview | Financials
Company Name Scholar Rock Holding Corporation
Symbol SRRK
Currency USD
Price 8.57
Market Cap 685,879,382
Dividend Yield 0%
52-week-range 5.94 - 21.17
Industry Biotechnology
Sector Healthcare
CEO Dr. Jay T. Backstrom M.D., M.P.H.
Website https://scholarrock.com

An error occurred while fetching data.

About Scholar Rock Holding Corporation

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3

Related Stocks

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

0.835 USD

Harrow Health, Inc. logo

Harrow Health, Inc.

HROW

45.14 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

13.86 USD

Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc.

ORMP

2.49 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

0.28 USD

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

34.48 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

5.69 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

66.73 USD

Financials

Numbers are in millions USD

Numbers are in millions USD